Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Compass Therapeutics stock

Learn how to easily invest in Compass Therapeutics stock.

Compass Therapeutics is a biotechnology business based in the US. Compass Therapeutics shares (CMPX) are listed on the NASDAQ and all prices are listed in US Dollars. Compass Therapeutics employs 26 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Compass Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CMPX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Compass Therapeutics stock price (NASDAQ: CMPX)

Use our graph to track the performance of CMPX stocks over time.

Compass Therapeutics shares at a glance

Information last updated 2023-09-17.
Latest market close$1.96
52-week range$1.81 - $5.65
50-day moving average $2.68
200-day moving average $3.51
Wall St. target price$9.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.37

Buy Compass Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Compass Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Compass Therapeutics price performance over time

Historical closes compared with the close of $1.96 from 2023-09-22

1 week (2023-09-15) -7.98%
1 month (2023-08-23) -21.91%
3 months (2023-06-23) -37.78%
6 months (2023-03-23) -37.97%
1 year (2022-09-23) -12.50%
2 years (2021-09-23) -44.00%
3 years (2020-09-19) N/A
5 years (2018-09-19) N/A

Compass Therapeutics financials

Gross profit TTM $0
Return on assets TTM -18.99%
Return on equity TTM -28.92%
Profit margin 0%
Book value $1.32
Market Capitalization $303.4 million

TTM: trailing 12 months

Compass Therapeutics share dividends

We're not expecting Compass Therapeutics to pay a dividend over the next 12 months.

Compass Therapeutics share price volatility

Over the last 12 months, Compass Therapeutics's shares have ranged in value from as little as $1.81 up to $5.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Compass Therapeutics's is 0.3872. This would suggest that Compass Therapeutics's shares are less volatile than average (for this exchange).

To put Compass Therapeutics's beta into context you can compare it against those of similar companies.

Compass Therapeutics overview

Compass Therapeutics, Inc. , a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts. .

Frequently asked questions

What percentage of Compass Therapeutics is owned by insiders or institutions?
Currently 15.687% of Compass Therapeutics shares are held by insiders and 64.965% by institutions.
How many people work for Compass Therapeutics?
Latest data suggests 26 work at Compass Therapeutics.
When does the fiscal year end for Compass Therapeutics?
Compass Therapeutics's fiscal year ends in December.
Where is Compass Therapeutics based?
Compass Therapeutics's address is: 80 Guest Street, Boston, MA, United States, 02135
What is Compass Therapeutics's ISIN number?
Compass Therapeutics's international securities identification number is: US20454B1044

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site